Research Papers

25 of 170 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Regenerative and translational medicine in COPD: hype and hope.
Guarnier LP; Moro LG; Lívero FADR; de Faria CA; Azevedo MF; Roma BP; Albuquerque ER; Malagutti-Ferreira MJ; Rodrigues AGD; da Silva AA; Sekiya EJ; Ribeiro-Paes JT.
Eur Respir Rev (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Natural killer cells in the lung: potential role in asthma and virus-induced exacerbation?
Lepretre F; Gras D; Chanez P; Duez C.
Eur Respir Rev (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Performance-based outcome measures to assess functionality in hospitalised patients with COPD exacerbations: a systemat…
Leonardi NT; Kawakami DMO; Hurst JR; Cruz J; Mendes RG.
Eur Respir Rev (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Ear and upper airway clinical outcome measures for use in primary ciliary dyskinesia research: a scoping review.
Alexandru M; Veil R; Rubbo B; Goutaki M; Kim S; Lam YT; Nevoux J; Lucas JS; Papon JF.
Eur Respir Rev (Unknown)
Published: 2023
2/6 Transparent
Physical activity measurements in individuals with interstitial lung disease: a systematic review and meta-analysis.
Iwakura M; Kawagoshi A; Tamaki A; Oki Y; Oshima Y; Spruit MA.
Eur Respir Rev (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
"Noninvasive respiratory support after extubation: a systematic review and network meta-analysis". A. Boscolo, T. Pette…
NA
Eur Respir Rev (Unknown)
Published: 2023
1/6 Transparent
The role of oral appliance therapy in obstructive sleep apnoea.
Johal A; Hamoda MM; Almeida FR; Marklund M; Tallamraju H.
Eur Respir Rev (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The role of diet and nutrition in the management of COPD.
Beijers RJHCG; Steiner MC; Schols AMWJ.
Eur Respir Rev (Unknown)
Published: 2023
2/6 Transparent
Extreme weather and asthma: a systematic review and meta-analysis.
Makrufardi F; Manullang A; Rusmawatiningtyas D; Chung KF; Lin SC; Chuang HC.
Eur Respir Rev (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models …
Dhana A; Gupta RK; Hamada Y; Kengne AP; Kerkhoff AD; Yoon C; Cattamanchi A; Reeve BWP; Theron G; Ndlangalavu G; Wood R; Drain PK; Calderwood CJ; Noursadeghi M; Boyles T; Meintjes G; Maartens G; Barr DA.
Eur Respir Rev (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Efficacy and safety of gefapixant for chronic cough: a meta-analysis of randomised controlled trials.
Chuang MH; Chen IW; Chen JY; Kang FC; Ho CN; Wu SC; Yew M; Lan KM; Hung KC.
Eur Respir Rev (Unknown)
Published: 2023
3/6 Transparent
Registered
Phenotype overlap in the natural history of asthma.
Ricciardolo FLM; Guida G; Bertolini F; Di Stefano A; Carriero V.
Eur Respir Rev (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The oesophageal balloon for respiratory monitoring in ventilated patients: updated clinical review and practical aspect…
Jonkman AH; Telias I; Spinelli E; Akoumianaki E; Piquilloud L.
Eur Respir Rev (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Identifying risk factors for COPD and adult-onset asthma: an umbrella review.
Holtjer JCS; Bloemsma LD; Beijers RJHCG; Cornelissen MEB; Hilvering B; Houweling L; Vermeulen RCH; Downward GS; Maitland-Van der Zee AH; P4O2 consortium.
Eur Respir Rev (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Furin as a therapeutic target in cystic fibrosis airways disease.
Douglas LEJ; Reihill JA; Montgomery BM; Martin SL.
Eur Respir Rev (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Awake prone positioning in acute hypoxaemic respiratory failure.
McNicholas BA; Ibarra-Estrada M; Perez Y; Li J; Pavlov I; Kharat A; Vines DL; Roca O; Cosgrave D; Guerin C; Ehrmann S; Laffey JG.
Eur Respir Rev (Unknown)
Published: 2023
2/6 Transparent
Cytokine-targeted therapies for asthma and COPD.
Schleich F; Bougard N; Moermans C; Sabbe M; Louis R.
Eur Respir Rev (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Noncoding RNAs in asthmatic airway smooth muscle cells.
Xiao B; Li L; Yao D; Mo B.
Eur Respir Rev (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Post-tuberculosis lung impairment: systematic review and meta-analysis of spirometry data from 14 621 people.
Ivanova O; Hoffmann VS; Lange C; Hoelscher M; Rachow A.
Eur Respir Rev (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
"Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD…
NA
Eur Respir Rev (Unknown)
Published: 2023
1/6 Transparent
Noninvasive respiratory support after extubation: a systematic review and network meta-analysis.
Boscolo A; Pettenuzzo T; Sella N; Zatta M; Salvagno M; Tassone M; Pretto C; Peralta A; Muraro L; Zarantonello F; Bruni A; Geraldini F; De Cassai A; Navalesi P.
Eur Respir Rev (Unknown)
Published: 2023
2/6 Transparent
Managing respiratory muscle weakness during weaning from invasive ventilation.
Bureau C; Van Hollebeke M; Dres M.
Eur Respir Rev (Unknown)
Published: 2023
2/6 Transparent
Nonpharmacological management of psychological distress in people with COPD.
Volpato E; Farver-Vestergaard I; Brighton LJ; Peters J; Verkleij M; Hutchinson A; Heijmans M; von Leupoldt A.
Eur Respir Rev (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Smoking cessation and vaccination.
Montes de Oca M; Laucho-Contreras ME.
Eur Respir Rev (Unknown)
Published: 2023
2/6 Transparent
Lung transplantation for COPD/pulmonary emphysema.
Verleden GM; Gottlieb J.
Eur Respir Rev (Unknown)
Published: 2023
2/6 Transparent